</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →

Zanamivir Bulk Active Substance

Zanamivir is a neuraminidase inhibitor antiviral in bulk form for manufacturing influenza treatments like Relenza inhalers. This mixed constituent product for therapeutic use is not retail-packed, fitting HTS 3003.90.0120 for antivirals.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

2933.59.95.00Higher: 6.5% vs Free

If as unmixed heterocyclic compound

Single chemical entities are classified in Chapter 29 based on structure, not therapeutic mixture.

3003.39Higher: 10% vs Free

If primarily antibiotic rather than antiviral

Anti-infectives are subdivided; antibiotics go to separate subheading within 3003.39.

3006.92.00Higher: 10% vs Free

If sterile and for wound closure use

Chapter notes limit 3006 to specific sterile surgical products, excluding general antivirals.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Comply with FDA import alerts for antivirals; provide GMP certification from manufacturer

Ensure cold chain documentation if required for stability; avoid temperature excursion pitfalls

Label as 'for further manufacturing' to prevent retail misclassification

Related Products under HTS 3003.90.01.20